Trump signs bill to give patients right to try drugs

@article{Dyer2018TrumpSB,
  title={Trump signs bill to give patients right to try drugs},
  author={O. Dyer},
  journal={British Medical Journal},
  year={2018},
  volume={361}
}
  • O. Dyer
  • Published 2018
  • Medicine
  • British Medical Journal
The US Congress has passed a controversial bill that effectively ends the Food and Drug Administration’s control over access to unapproved drugs sought by patients who believe that they have run out of other options.1 President Donald Trump signed the bill on 30 May. A few days earlier he said that it “gives people hope . . . They won’t have to fly to Africa, they won’t have to fly to South America, they won’t have to fly to Europe.” Trump misrepresented the current situation, saying that… Expand

Topics from this paper

“Right-to-Try” experimental drugs: an overview
  • V. Mahant
  • Medicine, Computer Science
  • Journal of Translational Medicine
  • 2020
TLDR
The pros and cons of experimental drugs, including a number of “cutting edge” scientific, clinical, and number of synergistic approaches such as artificial intelligence, machine learning, big data, data refineries, electronic health records, data driven clinical decisions and risk mitigation are reviewed. Expand
Ethics codes and use of new and innovative drugs
TLDR
Advice on the use of unproven drugs contained in major international codes and guidelines pertaining to medical ethics and biomedical research is presented, relevant to innovative off‐label applications of approved drugs and expanded access to investigational drugs. Expand
Widening the Lens
Translational medicines “Ecosystem”
  • V. Mahant
  • Medicine, Political Science
  • Journal of Translational Medicine
  • 2020

References

The Ethical Challenges of Compassionate Use.
Granting access to drugs, vaccines, biologics, and devices that have not yet been approved by governmental regulatory authorities is a growing challenge for physicians, public officials, patientExpand